Relapsed Acute Lymphoblastic Leukemia (ALL) Active Not Recruiting Phase 1 Trials for Selinexor (DB11942)
Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL)) | Active Not Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02091245 | Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML | Treatment |